Lacour et al (2001) also showed that doxorubicin and cisplatin did not increase membrane DR4 and DR5 expression in colon cancer cell lines, but did sensitise colon cancer cells to TRAIL-mediated apoptosis. This evidence concerns the gene TNFRSF10A and malignant colon neoplasm.